Browse the evidence

The intake of saturated fatty acids (SAFAs) is directly associated with coronary heart disease (CHD) mortality, with a hazard ratio of 1.28 for one standard deviation increase.

Practitioners should consider the impact of saturated fat intake on heart disease risk in middle-aged men.

The intake of mono-unsaturated fatty acids (MUFAs) is inversely associated with coronary heart disease (CHD) mortality, with a hazard ratio of 0.84 for one standard deviation increase.

Practitioners should encourage the intake of mono-unsaturated fats to potentially lower heart disease risk.

Tirzepatide is linked to a significantly reduced risk of overall hematologic malignancy (OR = 0.14, 95%CI = 0.03-0.60), particularly for lymphoma.

Tirzepatide may be a safer option for patients concerned about hematologic malignancies.

Chronic low-grade inflammation underlies psoriasis and hidradenitis suppurativa, which can worsen with obesity.

Weight management is crucial for patients with these skin diseases to prevent worsening of their conditions.

Obesity is the most powerful promoter of type 2 diabetes (T2DM) and increases the risk of many other metabolic and cardiovascular diseases.

Weight management is crucial for preventing and treating T2DM.

Controlling the activities of inflammatory mediators can reduce the incidence of chronic diseases.

Diet, exercise, and lifestyle choices should focus on managing inflammation.

Human obesity is associated with insulin resistance and results in metabolic abnormalities and cardiovascular complications.

Practitioners should be aware of the metabolic and cardiovascular risks associated with obesity.

GLP-1 receptor agonists (GLP-1RAs) may influence skeletal muscle through anti-inflammatory, antioxidant, and mitochondrial-supportive mechanisms.

Practitioners should consider the potential muscle-preserving effects of GLP-1RAs in patients at risk for sarcopenia.

GLP-1RAs have shown muscle-preserving properties in experimental models of aging, sarcopenic obesity, and chronic disease.

GLP-1RAs may be beneficial in preserving muscle in specific populations, such as the elderly or those with chronic diseases.

Visceral and ectopic fat accumulation strongly predicts adverse lipid patterns, insulin resistance, and cardiovascular events.

Focus on reducing visceral and ectopic fat to improve lipid profiles and reduce cardiovascular risk.

Obesity significantly influences the incidence and progression of various cancers.

Practitioners should consider obesity as a critical factor in cancer risk assessment.

Surgical therapies including laparoscopic bariatric surgery represent an important treatment strategy in obese patients.

Practitioners should consider bariatric surgery for eligible obese patients.

Expert consensus has defined a state of diabetes remission where treatment can induce sustained normalization of glucose levels.

Understanding this definition can help practitioners set realistic treatment goals.

MNs hold promise in improving the quality of life for individuals struggling with obesity and its associated comorbidities.

MNs may enhance treatment efficacy and patient outcomes in obesity management.

Sarcopenia is characterized by the progressive and generalized loss of muscle mass and strength, negatively impacting health and quality of life.

Understanding sarcopenia is crucial for developing interventions to improve health in aging populations.

Some studies showed a possible positive effect of phosphatidic acid on body composition and performance improvements.

While there may be some positive effects noted, the lack of consistent evidence suggests caution in recommending PA.

Bone mineral content (BMC) increased during the weight loss period, leading to a smaller reduction in fat-free mass (FFM) compared to LST.

Practitioners should note the increase in BMC during weight loss, which may influence overall body composition assessments.

The type of protein consumed can affect feeding- and exercise-mediated rates of MPS.

Choosing the right type of protein may enhance muscle recovery and growth post-exercise.

Lacto-ovo-vegetarians (LOV) and non-vegetarians (NV) showed similar increases in quadriceps femoris muscle thickness (QFMT) after 12 weeks of strength training (ST) (LOV: 9.2 ± 5.4 mm; NV: 5.5 ± 8.1 mm).

Both vegetarians and non-vegetarians can achieve similar muscle growth from strength training.

The importance of specific protein sources appears to differ by sex.

Further research is needed to understand how different protein sources affect lean mass in men and women.

Myofibrillar protein synthesis is positively correlated with blood pH.

Practitioners may need to consider blood pH levels when assessing muscle protein synthesis.

The COSIAM method provides a viable approach for assessing muscle protein turnover in young, healthy females.

Practitioners can use the COSIAM method for accurate assessment of muscle protein turnover in young females.

The effects of resistance training at longer muscle lengths show an increasing trend from proximal to distal sites.

Practitioners may consider the trend when designing resistance training programs, but should note the trivial nature of the differences.

Overemphasis on carbohydrate-to-fat ratio may explain disappointing outcomes in treating obesity and preventing type 2 diabetes.

Clinicians should consider the quality of diet, not just macronutrient ratios, when treating obesity.